Accelerating
clinical development

About Us

Matching the right treatment to the right patient where they receive care

Anova is realizing the promise of precision medicine, helping patients access promising investigational products wherever they receive care.

The world’s clinical development environment, at your fingertips

Our AnovaOS™ technology platform provides an integrated research network of 15k sponsors, 130k active studies, 15k investigational products, 44k+ research sites, and 100k+ investigators. We bring the world’s clinical research environment together for every treating physician.

The goal is to provide meaningful access, making all studies available to every research site. Treating physicians and research staff can efficiently match patients to promising new treatments, secure access and quickly enroll the patient to a clinical trial or compassionate use program. Direct access to key decision-makers at manufacturers enables just-in-time access to any investigational product.

AnovaOS™ is the catalyst that accelerates development of complex treatments for oncology, infectious disease, neurology, immunology, cardiology and rare disease.

About Us

Matching the right treatment to the right patient where they receive care

Anova is realizing the promise of precision medicine, helping patients access promising investigational products wherever they receive care.

The world’s clinical development environment, at your fingertips

Our AnovaOS™ technology platform provides an integrated research network of 4k sponsors, 130k active studies, 15k investigational products, 40k+ research sites, and 100k+ investigators. We bring the world’s clinical research environment together for every treating physician.

The goal is to provide meaningful access, making all studies available to every research site. Treating physicians and research staff can efficiently match patients to promising new treatments, secure access and quickly enroll the patient to a clinical trial or compassionate use program. Direct access to key decision-makers at manufacturers enables just-in-time access to any investigational product.

AnovaOS™ is the catalyst that accelerates development of complex treatments for oncology, infectious disease, neurology, immunology, cardiology and rare disease.

Your On-Demand Research Network

Any study, any patient, anywhere…

Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.

Our technology platform, AnovaOS™, enables sponsors and sites/physicians to connect, complete study feasibility, match patients to any study, activate and enrol patients just-in-time to any clinical trial, or apply for compassionate use of any of investigational product. Sponsors can access regulatory packages for streamlined submission and approval, collect quality data, monitor studies and integrate research pathways to accelerate development.

Get started now

Active Studies

0

Match any patient to any study, streamline activation & enrolment. Initiate data capture.

Your On-Demand Research Network

Any study, any patient, anywhere…

Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.

Our technology platform, AnovaOS™, enables sponsors and sites/physicians to connect, complete study feasibility, match patients to any study, activate and enrol patients just-in-time to any clinical trial, or apply for compassionate use of any of investigational product. Sponsors can access regulatory packages for streamlined submission and approval, collect quality data, monitor studies and integrate research pathways to accelerate development.

Get started now

What We Do

Welcome to the future of clinical development…

Sponsor & study registry

All sponsors and active studies are captured globally. Protocols are structured and eligibility criteria codified to match to patient clinical characteristics. Direct access to sponsor program leads provided for rapid activation and enrolment.

Site & physician qualification

Qualified site and personnel profiles captured with all research interests, regulatory credentials and operational capabilities readily available for site feasibility and qualification.

Patient matching

Patients matched to any of 130k+ active studies and 15k+ investigational products in development globally. Site capabilities, physician credentials, and patient clinical criteria used to match to studies. Just-in-time application for clinical trials or compassionate use enabled for all sponsors, all studies, all investigational products, and for all patients

Study activation & enrolment

Activate sites in 5 working days using master contract and fee schedule, with streamlined regulatory compliance.

Data capture and evidence generation

Integrated data capture and clinical evidence generation across product and indications.

Get started now

What We Do

Welcome to the future of clinical development…

Sponsor & study registry

All sponsors and active studies are captured globally. Protocols are structured and eligibility criteria codified to match to patient clinical characteristics. Direct access to sponsor program leads provided for rapid activation and enrolment.

Site & physician qualification

Qualified site and personnel profiles captured with all research interests, regulatory credentials and operational capabilities readily available for site feasibility and qualification.

Patient matching

Patients matched to any of 130k+ active studies and 15k+ investigational products in development globally. Site capabilities, physician credentials, and patient clinical criteria used to match to studies. Just-in-time application for clinical trials or compassionate use enabled for all sponsors, all studies, all investigational products, and for all patients

Study activation & enrolment

Activate sites in 5 working days using master contract and fee schedule, with streamlined regulatory compliance.

Data capture and evidence generation

Integrated data capture and clinical evidence generation across product and indications.

Get started now

Our platform members

Get started now

What our users say

“Anova’s forward-thinking approach to Expanded Access has brought Celularity investigational products to cancer and COVID-19 patients in need while generating data that has directly impacted our traditional development efforts.”

DR NASSIR HABBOUBI

CHIEF MEDICAL OFFICER

CELULARITY

“Anova and ERC crafted an ethical Right-to-Try program that has helped patients with brain tumors and generated survival data that has became integral to our regulatory submissions. When we secure marketing approval it will be, in part, due to our partnership with Anova.”

DR APOSTOLOS STATHOPOLOS

CEO & FOUNDER

ERC

“The South Sound Care Foundation supports providers across the South Sound region access targeted therapies for patients with cancer. Anova has been instrumental in helping our team establish a robust compassionate use program and providing the technology required to deliver seamless and compliant compassionate use for our providers.”

DR FRANC SENECAL

MEDICAL ONCOLOGIST, NW MEDICAL SPECIALTIES & FOUNDER, SSCF

SOUTH SOUND CARE FOUNDATION (SSCF)

“OPN Healthcare is a specialty healthcare services company focused on cancer care, with over 1 million covered lives. Our partnership with Anova has been helped us to establish a robust clinical research program across our practices in southern California and improve access to promising new treatments for our patients. Within our first six months of operation we have recruited dozens of patients into clinical trials and the program is continuing to grow rapidly.”

SRIN VISHWANATH

PRESIDENT/CEO

OPN HEALTHCARE

“Anova’s deep regulatory and technical expertise has helped our company navigate conflicts that can (and do) arise with traditional CRO partners. Ethical research that complies with regulatory requirements is a foundation of our work. On multiple occasions, Anova has recommended a path that has been validated by regulators to be the best approach for our company and our products for patients with herpes and COVID-19.”

AUGUSTIN FERNADEZ III

CEO

RATIONAL VACCINES

What our users say

“OPN Healthcare is a specialty healthcare services company focused on cancer care, with over 1 million covered lives. Our partnership with Anova has been helped us to establish a robust clinical research program across our practices in southern California and improve access to promising new treatments for our patients. Within our first six months of operation we have recruited dozens of patients into clinical trials and the program is continuing to grow rapidly.”

SRIN VISHWANATH

PRESIDENT/CEO

OPN HEALTHCARE

“Anova and ERC crafted an ethical Right-to-Try program that has helped patients with brain tumors and generated survival data that has became integral to our regulatory submissions. When we secure marketing approval it will be, in part, due to our partnership with Anova.”

DR APOSTOLOS STATHOPOLOS

CEO & FOUNDER

ERC

“Anova’s deep regulatory and technical expertise has helped our company navigate conflicts that can (and do) arise with traditional CRO partners. Ethical research that complies with regulatory requirements is a foundation of our work. On multiple occasions, Anova has recommended a path that has been validated by regulators to be the best approach for our company and our products for patients with herpes and COVID-19.”

AUGUSTIN FERNADEZ III

CEO

RATIONAL VACCINES

“Anova’s forward-thinking approach to Expanded Access has brought Celularity investigational products to cancer and COVID-19 patients in need while generating data that has directly impacted our traditional development efforts.”

DR NASSIR HABBOUBI

CHIEF MEDICAL OFFICER

CELULARITY

“The South Sound Care Foundation supports providers across the South Sound region access targeted therapies for patients with cancer. Anova has been instrumental in helping our team establish a robust compassionate use program and providing the technology required to deliver seamless and compliant compassionate use for our providers.”

DR FRANC SENECAL

MEDICAL ONCOLOGIST, NW MEDICAL SPECIALTIES & FOUNDER, SSCF

SOUTH SOUND CARE FOUNDATION (SSCF)

Register today, connect your research network and accelerate your research program.

Get started now

Accelerating clinical development

About Us

Matching the right treatment to the right patient where they receive care

About Us

Matching the right treatment to the right patient where they receive care

Your On-Demand Research Network

Any study, any patient, anywhere…

Your On-Demand Research Network

Any study, any patient, anywhere…

What We Do

Welcome to the future of clinical development…

What We Do

Welcome to the future of clinical development…

Our platform members

What our users say

What our users say

Register today, connect your research network and accelerate your research program.

Accelerating
clinical development